A systematic evaluate of VIP in experimental autoimmune encephalomyelitis (the MS model) located that VIP administration minimized clinical severity scores by 40–65% across 12 independent studies, with histological analysis demonstrating lessened CNS infiltration of Th1 and Th17 cells and greater Foxp3+ Tregs inside the spinal wire.These ap… Read More